Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

STAGE PROGRESSION IN TA PAPILLARY UROTHELIAL TUMORS: RELATIONSHIP TO GRADE, IMMUNOHISTOCHEMICAL EXPRESSION OF TUMOR MARKERS, MITOTIC FREQUENCY AND DNA PLOIDY

1 Apr 2001

Abstract excerpt

PURPOSE: We studied 363 patients with stage Ta bladder tumors during long-term followup who were classified according to the 1998 WHO and International Society of Urological Pathology consensus classifications. We determine whether various immunohistochemical and molecular markers could predict tumor progression. MATERIALS AND METHODS: A total of 680 patients in western Sweden with a first diagnosis of bladder...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Multiple and Secondary Primary Cancers
Share to Urinary and Genital Oncology Studies

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 11257652
DOI: 10.1016/s0022-5347(05)66443-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

STAGE PROGRESSION IN TA PAPILLARY UROTHELIAL TUMORS: RELATIONSHIP TO GRADE, IMMUNOHISTOCHEMICAL EXPRESSION OF TUMOR MARKERS, MITOTIC FREQUENCY AND DNA PLOIDYPMID 11257652Read ↗

Predicting recurrence and progression of noninvasive papillary bladder cancer at initial presentation based on quantitative gene expression profiles.Semantic proximity Read ↗

Analysis of papillary urothelial carcinomas of the bladder with grade heterogeneity: supportive evidence for an early role of <i><scp>CDKN</scp>2A</i> deletions in the <i><scp>FGFR</scp>3</i> pathwaySemantic proximity Read ↗

Prediction of progression of non-muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a prospective study.Semantic proximity Read ↗

[Update on urothelial carcinoma histopathology].Semantic proximity Read ↗

Correlation of allelic loss of the P53 gene and tumor grade, stage, and malignant progression in bladder cancer.Semantic proximity Read ↗

FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumours.Semantic proximity Read ↗

Diagnostic and Prognostic Implications of FGFR3high/Ki67high Papillary Bladder Cancers.Semantic proximity Read ↗

Cyclin D1 expression in papillary superficial bladder cancer: Its association with other cell cycle‐associated proteins, cell proliferation and clinical outcomeSemantic proximity Read ↗

Chromosomal imbalance in the progression of high-risk non-muscle invasive bladder cancer.Semantic proximity Read ↗

Loss of adipocyte-type fatty acid binding protein and other protein biomarkers is associated with progression of human bladder transitional cell carcinomas.Semantic proximity Read ↗

Noninvasive low-grade papillary urothelial carcinoma with degenerative nuclear atypia: a grading pitfall.Semantic proximity Read ↗

Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: comparison with DNA ploidy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.